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DD Non-DD p value
Mean PA Pressure (mmHg) 52 ± 4 53 ± 3 0.84
PCWP(mmHg) 5± 1 6± 1 059
Cardiac Output (Umin) 5.12±043 2.65 ± 021 000007
PVR (Wood Unitsl 10.0 ± 13 19.3 ± 2.4 0004
RA Pressure (mmHg) 5 ± 1 10 ± 2 008
RVID(cm) 3.1 ± 0.3 37 ± 0.2 008
NYHA Class 22 ± 0.3 33 ± 02 0.02
a role for angiotensin II (Ang II) in the pulmonary vasoconstriction and pul-
monary vascular smooth muscle proliferation characteristic of this disorder,
we hypothesize a compensatory role for Ang II in the maintenance of right
ventricular (RV) function in such patients. We evaluated the frequency of the
ACE DD genotype in 55 patients with severe primary pulmonary hyperten-
sion (PPH) and compared clinical severity and right heart hemodynamics at
the time of presentation in 20 of these patients stratified on the basiw of their
ACE genotype (DD vs non-DD, n = 10 in each group). The incidence of the
ACE DD genotype was 49% in the PPH patients compared to 23% in a con-
trol population (n = 89, P = 0.0009). Mean ± SEM right heart hemodynamics,
echocardiographic RV internal dimensions (RVID) and NYHA classifications
for the 2 groups are shown below:
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at study entry. No changes in global or regional wall motion were observed.
LV shortening fraction and diastolic and systolic LV diameters remained un-
changed during follow-up (35.4 ± 4% vs 35.6 ± 3%, 49.6 ± 3 vs 49.4 ±
3 mm, and 32 ± 2 vs 31.7 ± 2 respectively), Only 1 pt developed conges-
tive heart failure (LVEF dropped from 57% to 30%). Two patients developed
conduction abnormalities and 8 systemic hypertension. During follow up 29
pts were hospitalized for a suspected MI (5 pts) or unstable angina (24 pts),
Owing to chest pain 25 pts were severely limited and 7 abandoned work.
Although chest pain in syndrome X seems to be cardiac in origin and the
exercise test is positive, an ischemic origin can be demonstrated in only a
small proportion of pts. Cardiac mortality was not observed and a decline of
LVEF is not a frequent event.
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Are Indirect Markers an Accurate Measure of Free
Radical Activity Following Primary Angioplasty
Reperfusion in Acute Myocardial Infarction?
Ever D. Grech, Nicholas J. Dodd, E. Brian Faragher, Ronald A. Muirhead, Malcolm
J. Jackson, David R. Ramsdale. The Cardiothoracic Centre, Liverpool. UK
Oxygen-derived free radicals (FR) have been found to be important media-
tors of myocardial reperfusion injury in animal studies. In man, most studies
of FR measurement after reperfusion have relied on indirect markers alone.
However, their accuracy and relationship to FR's has been controversial. We
have therefore used primary PTCA for AMI as a model of acute reperfusion
to compare direct FR measurement using electron paramagnetic resonance
(EPR) spectroscopy and the spin trap agent a-phenyl N-tert butyl nitrone,
with two of the most commonly used indirect markers, These were: [1 J the
percentage molar ratio (PMR) of the diene conjugate 9,11-octa-decadieneoic
acid to the naturally-occurring isomer 9,12-linoleic acid, and [2) serum mal-
onaldehyde (MDA).
16 patients (mean age: 56.9 yrs, range 47-66). undergoing successful pri-
mary PTCA (8 LAD, 1 Intermed, 1 LCx, 6 RCA) of less than 6 h duration
(mean 3.55 h, range 2.25-5.0). had venous sampling from the base of the
right atrium/coronary sinus before angioplasty (TIMI 0) and at timed intervals
up to 24 h after recanalisation (TIMI 3).
Direct FR measurement using EPR showed a biphasic time-course. Rel-
ative to the pre-PTCA level, FR's increased sharply after 15 min (P < 0.05)
with peak levels at 1'I, and 3'1, h (P < 0.001). Following a decline to 6 h a
late peak was observed at 24 h which may originate from accumulating my-
ocardialleukocyte infiltration. Indirect FR measurement using PMR showed
a significant increase between 15 min and 1'I, h (P < 0.01) only. MDA levels
remained unchanged throughout the study.
These results demonstrate that compared to direct FR measurement us-
ing EPR, indirect markers used in this study have limited or no usefulness
in assessing FR generation in AMI. Myocardial reperfusion studies in man
should ideally use direct methods.
In a randomized, double-blind, placebo controlled trial (ASPECT) we studied
3404 post-myocardial infarction patients who suffered a stroke during long-
term anticoagulant therapy. The duration of treatment ranged from 1 day to
six years. Three years following randomization, 2% of the patients on anti-
coagulant therapy had a stroke compared to 4% in placebo.
The incidence of stroke analyzed on "intention-to-treat" was 0.7 per 100
patient-years in the anticoagulant group and 1.2 per 100 patient-years in
placebo, a hazard ratio (HR) of 0.60 with a 95% confidence interval (CI)of 0.40
to 0.90, a 40% reduction in the risk of stroke in the anticoagulated group, A
total of 19 intracranial bleeding was observed. The risk of hemorrhages was
8 times greater for anticoagulated patients compared to placebo. Eight of
the 17 bleedings were fatal in the anticoagulant group and no fatal hemor-
rhages occurred in placebo. A total of 15 cerebral infarctions occurred in the
anticoagulated group and 43 in placebo. Of the 14 hemorrhagic strokes, 6
were within INR 3.0-4.0 and 8 with an INR > 4,0, Of the 7 non-hemorrhagic
strokes, 2 were at INR < 2, 3 within INR 3.0-4.0, 1 at INR > 4.0, and no mea-
surementwas available in one patient. The total number of patients who died
or were severely disabled as a result of cerebral stroke amounted to 13 in
the anticoagulated group, compared to 18 in placebo.
Conclusion: The results of the ASPECT trial indicated that long-term anti-
coagulant therapy substantially reduced the risk of stroke in post-myocardial
infarction patients. The increased risk of bleeding complications associated
with anticoagulant therapy was offset by a marked reduction in ischemic
events.
Long Term Evolution of Left Ventricular Function
in Patients with Syndrome X
Giuseppe M.e. Rosano, Juan Carlos Kaski, Petros Nihoyannopoulos, Philip A
Poole-Wilson. National Heart & Lung Institute and Hammersmith Hospital, London. UK
The long-term follow up and the evolution of left ventricular function of syn-
drome X (SX) have not been investigated in large and homogeneous patient
populations. We followed the clinical course and the evolution of left ventric-
ular (LV) function in 99 pts (78 women, 21 men; mean age 54.9 ± 7 years)
during a mean follow-up of 6.7 ± 4 years. Patients underwent exercise test-
ing and echocardiographic assessment of LV function at study entry and at
follow up. All pts had positive exercise tests and 64 had transient ST depres-
sion on Holter monitoring. Transient myocardial ischemia was documented
in 32% of pts by means other than the ECG. During follow up, no deaths or
major cardiac events occurred. Exercise tests were positive at follow-up and
no differences in exercise test variables were observed compared with tests
Stress-induced Subendocardial Underperfusion:
A Potential Mechanism of Ischemia in
Hypertrophic Cardiomyopathy (HCM)
Significantly, the duration of symptoms attributable to PPH was not dif-
ferent between the DD and non-DD groups (35 ± 19 vs 22 ± 6 months, p
= 0.58). Conclusion: The ACE DD genotype is associated with preserved RV
function in PPH patients, supporting a compensatory myocardial or inotropic
role for Ang II in PPH.
Myocardial ischaemia is known to occur in patients with HCM, despite an-
giographically normal coronaries. However, the precise mechanism for this
phenomenon is unknown. Preliminary work with positron emission tomogra-
phy(PET) has demonstrated selective subendocardial underperfusion during
stress in some patients with very thick interventricular septa. To investigate
this further, we measured regional myocardial blood flow [MBF (ml/min/glJ.
at baseline and following infusion of dipyridamole (Dip, 056 mglkg over 4
minutes), using H2 15 0 or 13NH3 and PET in 22 patients with HCM, mean
age 39 ± 9 years. The thickness of the interventricular septum and the left
ventricular free wall were 26 ± 5 and 15 ± 5 mm respectively. Values of MBF
were calculated in the subendocardial (endo). and subepicardial (epi) regions
of the interventricular septum. Coronary vasodilator reserve (CVRI was calcu-
lated as Dip/baseline MBF. Results: At baseline endo-MBF was 0.87 ± 0.36
and epi-MBF 0.80 ± 0.34 (p = NS), resulting in an endolepi flow ratio of 1.09
± 0.28. Following Dip, endo-MBF was 1.13 ± 0.43 and epi-MBF 1.44 ± 0.44,
resulting in an endolepi flow ratio of 0.80 ± 0.22 (p < 0.001 vs baseline). In
13/22 patients (59%), the endolepi ratio decreased to less than 0.80 follow-
ing Dip (animal data show that normally the endo/epi ratio is close to 1 and
ranges between 0.8 and 1.2, both at baseline and during maximal coronary
vasodilatation I. The CVR was 1.33 ± 0.53 in the endo and 1.95 ± 0.70 in the
epi (p < 0.01). A linear relation (R = 0,58, p < 0.01) could be demonstrated
between endo-CVR and the endolepi ratio following Dip Conclusions: 1) Dip-
induced subendocardial underperfusion occurs frequently in HCM; 2) This
appears to be associated with a more impaired CVR in this layer; 3) Transmu-
ral maldistribution of MBF during stress may be a mechanism of ischaemia
in these patients despite normal coronaries.
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